Benjamin Eckhardt is an Infectious Disease physician affiliated with NYU Langone Health. OpenAlex indexes 55 publications with 1,349 citations (h-index 18); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
550 1st Ave
Nbv 16s 13
New York, NY 100166402
Telephone
212-263-6400Registry record last updated 16 Jun 2016.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
40.9%Statin19.7%Atorvastatin Calcium79%Pravastatin Sodium12%Rosuvastatin Calcium10%Part D<11 patientsCalcium channel blocker10%Amlodipine Besylate100%Part D<11 patients+ 3 more classes in this area
Anti-infectives
24.8%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor10.5%Tivicay67%Juluca33%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor6.9%Descovy67%Triumeq33%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
12.7%Insulin Analog4%Novolog Flexpen52%Basaglar Kwikpen U-10048%Part D<11 patientsGLP-1 receptor agonist4%Mounjaro100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 450. Antibiotic Fills and Readmissions After Patient-Directed Discharge in Drug Use-Associated Endocarditis: A National Medicaid Study
Open Forum Infectious Diseases
2026 - Providers’ Perspectives on Implementation of Low-threshold HCV Treatment in New York State: A Qualitative Study
Open Forum Infectious Diseases
2025 - SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir
The Journal of Infectious Diseases
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Harvey Pass, MD
NYU Langone Health
Gareth Morgan, MD
NYU Langone Health
Douglas Kondziolka, MD
NYU Langone Health
Nathan Levin, MD
NYU Langone Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”